509 related articles for article (PubMed ID: 34206432)
1. The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update.
Eckenstaler R; Benndorf RA
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206432
[TBL] [Abstract][Full Text] [Related]
2. ABCG2 as a therapeutic target candidate for gout.
Fujita K; Ichida K
Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
[TBL] [Abstract][Full Text] [Related]
3. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia.
Pálinkás M; Szabó E; Kulin A; Mózner O; Rásonyi R; Juhász P; Nagy K; Várady G; Vörös D; Zámbó B; Sarkadi B; Poór G
Clin Exp Med; 2023 Aug; 23(4):1277-1284. PubMed ID: 35939175
[TBL] [Abstract][Full Text] [Related]
5. The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion.
Hoque KM; Dixon EE; Lewis RM; Allan J; Gamble GD; Phipps-Green AJ; Halperin Kuhns VL; Horne AM; Stamp LK; Merriman TR; Dalbeth N; Woodward OM
Nat Commun; 2020 Jun; 11(1):2767. PubMed ID: 32488095
[TBL] [Abstract][Full Text] [Related]
6. Functional Characterization of Clinically-Relevant Rare Variants in
Toyoda Y; Mančíková A; Krylov V; Morimoto K; Pavelcová K; Bohatá J; Pavelka K; Pavlíková M; Suzuki H; Matsuo H; Takada T; Stiburkova B
Cells; 2019 Apr; 8(4):. PubMed ID: 31003562
[TBL] [Abstract][Full Text] [Related]
7. The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis.
Lukkunaprasit T; Rattanasiri S; Turongkaravee S; Suvannang N; Ingsathit A; Attia J; Thakkinstian A
BMC Med Genet; 2020 Oct; 21(1):210. PubMed ID: 33087043
[TBL] [Abstract][Full Text] [Related]
8. The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients.
Stiburkova B; Pavelcova K; Pavlikova M; Ješina P; Pavelka K
Arthritis Res Ther; 2019 Mar; 21(1):77. PubMed ID: 30894219
[TBL] [Abstract][Full Text] [Related]
9. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.
Woodward OM; Köttgen A; Coresh J; Boerwinkle E; Guggino WB; Köttgen M
Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10338-42. PubMed ID: 19506252
[TBL] [Abstract][Full Text] [Related]
10. ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload.
Matsuo H; Nakayama A; Sakiyama M; Chiba T; Shimizu S; Kawamura Y; Nakashima H; Nakamura T; Takada Y; Oikawa Y; Takada T; Nakaoka H; Abe J; Inoue H; Wakai K; Kawai S; Guang Y; Nakagawa H; Ito T; Niwa K; Yamamoto K; Sakurai Y; Suzuki H; Hosoya T; Ichida K; Shimizu T; Shinomiya N
Sci Rep; 2014 Jan; 4():3755. PubMed ID: 24441388
[TBL] [Abstract][Full Text] [Related]
11. ABCG2 dysfunction increases the risk of renal overload hyperuricemia.
Matsuo H; Takada T; Nakayama A; Shimizu T; Sakiyama M; Shimizu S; Chiba T; Nakashima H; Nakamura T; Takada Y; Sakurai Y; Hosoya T; Shinomiya N; Ichida K
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):266-74. PubMed ID: 24940678
[TBL] [Abstract][Full Text] [Related]
12. Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2.
Toyoda Y; Pavelcová K; Klein M; Suzuki H; Takada T; Stiburkova B
Arthritis Res Ther; 2019 Oct; 21(1):219. PubMed ID: 31661014
[No Abstract] [Full Text] [Related]
13. [Uric Acid Metabolism, Uric Acid Transporters and Dysuricemia].
Ichida K
Yakugaku Zasshi; 2024; 144(6):659-674. PubMed ID: 38825475
[TBL] [Abstract][Full Text] [Related]
14. Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects.
Takei R; Cadzow M; Markie D; Bixley M; Phipps-Green A; Major TJ; Li C; Choi HK; Li Z; Hu H; ; Guo H; He M; Shi Y; Stamp LK; Dalbeth N; Merriman TR; Wei WH
J Hum Genet; 2021 Feb; 66(2):161-169. PubMed ID: 32778763
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of the gout-associated polymorphism rs2231142 G>T in ABCG2 in a pregnant female Filipino cohort.
Roman Y; Tiirikainen M; Prom-Wormley E
Clin Rheumatol; 2020 Aug; 39(8):2387-2392. PubMed ID: 32107664
[TBL] [Abstract][Full Text] [Related]
16. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
Torres RJ; Puig JG
Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of ABCG2-mediated extra-renal urate excretion in hemodialysis patients.
Ohashi Y; Toyoda M; Saito N; Koizumi M; Kanai G; Komaba H; Kimura M; Wada T; Takahashi H; Takahashi Y; Ishida N; Kakuta T; Fukagawa M; Ichida K
Sci Rep; 2023 Jan; 13(1):93. PubMed ID: 36639673
[TBL] [Abstract][Full Text] [Related]
18. Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout.
Dong Z; Zhou J; Jiang S; Li Y; Zhao D; Yang C; Ma Y; He H; Ji H; Jin L; Zou H; Wang J
Hereditas; 2020 Jan; 157(1):2. PubMed ID: 32000861
[TBL] [Abstract][Full Text] [Related]
19. Medically Important Alterations in Transport Function and Trafficking of ABCG2.
Homolya L
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801813
[TBL] [Abstract][Full Text] [Related]
20. [Recent progress and prospects for research on urate efflux transporter ABCG2].
Ichida K
Nihon Rinsho; 2014 Apr; 72(4):757-65. PubMed ID: 24796111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
